Elective Percutaneous Coronary Intervention in Ambulatory Surgery Centers

被引:6
|
作者
Li, Kevin [1 ]
Kalwani, Neil M. [2 ]
Heidenreich, Paul A. [2 ]
Fearon, William F. [2 ]
机构
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Stanford Cardiovasc Inst, Div Cardiovasc Med, 300 Pasteur Dr,H2103, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
ischemic heart disease; outcomes; PCI; percutaneous coronary intervention; health services research; SAME-DAY DISCHARGE; TEMPORAL TRENDS; ANGIOGRAPHY; MORTALITY; OUTCOMES; ACCESS; IMPACT; RISK; SITE;
D O I
10.1016/j.jcin.2020.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to explore characteristics and outcomes of patients undergoing elective percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs). BACKGROUND Little is known about patients who underwent ASC PCI before Medicare reimbursement was instituted in 2020. METHODS Using commercial insurance claims from MarketScan, adults who underwent hospital outpatient department (HOPD) or ASC PCI for stable ischemic heart disease from 2007 to 2016 were studied. Propensity score analysis was used to measure the association between treatment setting and the primary composite outcome of 30-day myocardial infarction, bleeding complications, and hospital admission. RESULTS The unmatched sample consisted of 95,492 HOPD and 849 ASC PCIs. Patients who underwent ASC PCI were more likely to be younger than 65 years, to live in the southern United States, and to have managed or consumer-driven health insurance. ASC PCI was also associated with decreased fractional flow reserve utilization (odds ratio [OR]: 0.31; 95% confidence interval [CI]: 0.20 to 0.48; p < 0.001). In unmatched, multivariate analysis, ASC PCI was associated with increased odds of the primary outcome (OR: 1.25; 95% CI: 1.01 to 1.56; p = 0.039) and bleeding complications (OR: 1.80; 95% CI: 1.11 to 2.90; p = 0.016). In propensity-matched analysis, ASC PCI was not associated with the primary outcome (OR: 1.23; 95% CI: 0.94 to 1.60; p = 0.124) but was significantly associated with increased bleeding complications (OR: 2.49; 95% CI: 1.25 to 4.95; p = 0.009). CONCLUSIONS Commercially insured patients undergoing ASC PCI were less likely to undergo fractional flow reserve testing and had higher odds of bleeding complications than HOPD-treated patients. Further study is warranted as Medicare ASC PCI volume increases. (J Am Coll Cardiol Intv 2021;14:292-300) Published by Elsevier on behalf of the American College of Cardiology Foundation
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [1] Elective Percutaneous Coronary Intervention in Ambulatory Surgery Centers Is This a Bridge Too Far?
    Dehmer, Gregory J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (03) : 301 - 303
  • [2] SCAIposition statement on the performance of percutaneous coronary intervention in ambulatory surgical centers
    Box, Lyndon C.
    Blankenship, James C.
    Henry, Timothy D.
    Messenger, John C.
    Cigarroa, Joaquin E.
    Moussa, Issam D.
    Snyder, Richard W.
    Duffy, Peter L.
    Carr, Jeffrey G.
    Tukaye, Deepali N.
    Ang, Lawrence
    Shah, Binita
    Rao, Sunil, V
    Mahmud, Ehtisham
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (04) : 862 - 870
  • [3] Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
    Grodzinsky, Anna
    Kosiborod, Mikhail
    Tang, Fengming
    Jones, Philip G.
    McGuire, Darren K.
    Spertus, John A.
    Beltrame, John F.
    Jang, Jae-Sik
    Goyal, Abhinav
    Butala, Neel M.
    Yeh, Robert W.
    Arnold, Suzanne V.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (09):
  • [4] Clopidogrel Before Elective Percutaneous Coronary Intervention
    Motovska, Zuzana
    Widimsky, Petr
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04) : 373 - 379
  • [5] Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study
    Sun, Shengjia
    Ou, Yang
    Shi, Haiming
    Luo, Jianfeng
    Luo, Xinping
    Shen, Yunzhi
    Chen, Yufei
    Liu, Xiaojin
    Zhu, Zhidong
    Shen, Wei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (03)
  • [6] Cost-effectiveness and Outcomes with Early or Same-Day Discharge After Elective Percutaneous Coronary Intervention
    Koshy, Santhosh K. G.
    George, Lekha K.
    Das, Pranab
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (06)
  • [7] Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials
    Rashid, Muhammad
    Stevens, Chris
    Wijeysundera, Harindra C.
    Curzen, Nick
    Khoo, Chee Wah
    Mohamed, Mohamed Osama
    Aktaa, Suleman
    Wu, Jianhua
    Ludman, Peter F.
    Mamas, Mamas A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
  • [8] Ambulatory transradial percutaneous coronary intervention: A safe, effective, and cost-saving strategy
    Le Corvoisier, Philippe
    Gellen, Barnabas
    Lesault, Pierre-Francois
    Cohen, Remy
    Champagne, Stephane
    Duval, Anne-Marie
    Montalescot, Gilles
    Elhadad, Simon
    Montagne, Olivier
    Durand-Zaleski, Isabelle
    Dubois-Rande, Jean-Luc
    Teiger, Emmanuel
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (01) : 15 - 23
  • [9] Variation in Practice and Concordance with Guideline Criteria for Length of Stay After Elective Percutaneous Coronary Intervention
    Din, Jehangir N.
    Snow, Thomas M.
    Rao, Sunil V.
    Klinke, W. Peter
    Nadra, Imad J.
    Della Siega, Anthony
    Robinson, Simon D.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 90 (05) : 715 - 722
  • [10] Same-day discharge after elective percutaneous coronary intervention: A single center experience
    Rodrigues, Alberto
    Silva, Mariana
    Almeida, Carla
    Ferreira, Francisco Castro
    de Morais, Gustavo Pires
    Santos, Lino
    Melica, Bruno
    Braga, Pedro
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (08) : 443 - 449